首页> 外文OA文献 >The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases – recommendations of the IRDiRC Data Mining and Repurposing Task Force

【2h】

The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases – recommendations of the IRDiRC Data Mining and Repurposing Task Force

机译：使用或产生生物医学数据和现有药物，以发现和建立罕见疾病患者的新治疗方法 - IRDIRC数据挖掘和重新制备工作队的建议

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Noel T Southall; Madhusudan Natarajan; Lilian Pek Lian Lau; Anneliene Hechtelt Jonker; Benoît Deprez; Tim Guilliams; Lawrence Hunter; Carin MA Rademaker; Virginie Hivert; Diego Ardigò;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. The International Society for Pharmacoepidemiology's Comments on the Core Recommendations in the Summary of the Heads of Medicines Agencies (HMA) ‐ EMA Joint Big Data Task Force [J] . Anton Potteg?rd, Olaf Klungel, Almut Winterstein, Pharmacoepidemiology and drug safety . 2019,第12期

机译：国际药物期权学会对药品机构头部摘要（HMA） - EMA联合大数据工作组的核心建议的评论
2. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease) - Summary of Recommendations [J] . Hirsch AT, Haskal ZJ, Hertzer NR, Journal of vascular and interventional radiology: JVIR . 2006,第9期

机译：ACC / AHA外周动脉疾病（下肢，肾，肠系膜和腹主动脉）患者管理指南：美国血管外科协会/血管外科协会，心血管血管造影和介入学会，血管医学和生物学，介入放射学学会以及ACC / AHA实践指南工作组（制定《外周动脉疾病患者治疗指南》编写委员会）-建议摘要
3. 2013 ACCF/AHA Key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: A report of the American college of cardiology foundation/American Heart Association Task force on Clinical Data Standards (Writing committee to develop acute coronary syndromes and coronary artery disease clinical data standards) [J] . CannonC.P., BrindisR.G., ChaitmanB.R., Circulation: An Official Journal of the American Heart Association . 2013,第9期

机译：2013 ACCF / AHA衡量急性冠脉综合征和冠心病患者的临床管理和结局的关键数据要素和定义：美国心脏病学会基金会/美国心脏协会临床数据标准工作组的报告（制定急性冠状动脉综合征和冠状动脉疾病的临床数据标准）
4. Intelligent Analysis and Research on Clinical Data of Traditional Chinese Medicine Diagnosis and Treatment of Coronary Heart Disease Based on Data Mining [C] . Kun Zhang, Xiaoyan Chen, Haifeng Wang, International Conference on Mechatronics, Materials, Chemistry and Computer Engineering . 2017

机译：基于数据挖掘的中医诊断和冠心病患者临床数据智能分析与研究
5. Achieving Personalized Medicine Using Machine Learning: Clinical Data Mining Studies on Coronary Heart Disease, Substance Use Disorder, and Alzheimer’s Disease [D] . Hu, Ziheng. 2019

机译：使用机器学习实现个性化医学：冠心病，物质使用障碍和阿尔茨海默病的临床数据挖掘研究
6. The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases – recommendations of the IRDiRC Data Mining and Repurposing Task Force [O] . Noel T Southall, Madhusudan Natarajan, Lilian Pek Lian Lau, 2019

机译：利用或生成生物医学数据和现有药物来发现和建立罕见病患者的新疗法– IRDiRC数据挖掘和再利用工作组的建议
7. Measuring what matters to rare disease patients – reflections on the work by the IRDiRC taskforce on patient-centered outcome measures [O] . Thomas Morel, Stefan J. Cano 2017

机译：衡量对罕见疾病患者至关重要的事项 - IRDiRC工作组对以患者为中心的结局指标的工作的反思

The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases – recommendations of the IRDiRC Data Mining and Repurposing Task Force

著录项

引文网络

相似文献

相关主题

期刊订阅